0001967940-23-000018.txt : 20230612 0001967940-23-000018.hdr.sgml : 20230612 20230612143450 ACCESSION NUMBER: 0001967940-23-000018 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20230612 DATE AS OF CHANGE: 20230612 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: ACADIA PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001070494 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 061376651 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 000-50768 FILM NUMBER: 231007731 BUSINESS ADDRESS: STREET 1: 3611 VALLEY CENTRE DRIVE STREET 2: SUITE 300 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: 858-558-2871 MAIL ADDRESS: STREET 1: 3611 VALLEY CENTRE DRIVE STREET 2: SUITE 300 CITY: SAN DIEGO STATE: CA ZIP: 92130 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: Brege Laura CENTRAL INDEX KEY: 0001365619 FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: C/O ONYX PHARMACEUTICALS, INC. STREET 2: 2100 POWELL STREET CITY: EMERYVILLE STATE: CA ZIP: 94608 144 1 primary_doc.xml 144 0001365619 XXXXXXXX LIVE 0001070494 ACADIA PHARMACEUTICALS INC 000-50768 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO MN 92130 858-558-2871 Brege Laura Director common Piper Sandler & Co.

800 Nicollet Mall, Ste 900 Minneapolis MN 55402

4500 112240.00 162630000 06/12/2023 NASDAQ Common 06/01/2023 Vested RSU shares Issuer N 4500 06/01/2023 Equity award Y 06/12/2023 11/14/2022 /s/ Linda Moran, as a duly authorized representative of Piper Sandler & Co Corporate & Venture Services FA, as attorney-in-fact for Laura Brege